2 Months Post-Surgery, Patient Returns To Normal Life After Wide-Glossectomy With Microvascular Reconstruction

▴ tongue cancer
Post-surgery, Dr Harshita's journey continued with radiation and chemotherapy to combat her node-positive disease. Two months after completing her treatment, her scans revealed normal results, indicating a positive trajectory in her recovery journey.

Nashik, April 30: A resident of Dhule, 25-year-old medical graduate - Dr Harshita recently marked a significant milestone in her journey as she triumphed over tongue cancer and is now gearing up to specialize in oncology, showcasing the resilience and determination of cancer survivors. Having recently completed her internship and on the verge of pursuing a super PG NEET examination to specialize in dermatology, Dr Harshita encountered a surprising turn of events. Despite her youth and absence of common risk factors like tobacco use, she discovered a persistent ulcer on her tongue. What seemed like a minor issue at first turned out to be a diagnosis of tongue cancer after a biopsy at HCG Manavata Cancer Centre (HCGMCC) conducted last October.

“Harshita's concerns extended beyond the health implications of cancer. The prospect of potential disfigurement post-surgery weighed heavily on her, especially considering her focus on completing her education and pursuing a career in medicine. However, with her sheer grit and resilience, and the guidance and assurance from our team, she underwent a wide-glossectomy with microvascular reconstruction a few days post the biopsy, addressing neck dissection as well,” says Dr Raj Nagarkar, Managing Director & Chief of Surgical Oncology & Robotic Services, HCG Manavata Cancer Centre (HCGMCC) & Hospitals.

Post-surgery, Dr Harshita's journey continued with radiation and chemotherapy to combat her node-positive disease. Two months after completing her treatment, her scans revealed normal results, indicating a positive trajectory in her recovery journey.

“Returning to her regular duties and with renewed vigour, Dr Harshita surprised everyone by sharing her new career aspiration during a follow-up session at the hospital. She expressed her desire to specialize in oncology, inspired by her personal experience and the support she received during her cancer treatment. Her story serves as a beacon of hope and spirit, showcasing that despite the challenges posed by cancer, there is always a silver lining. Her determination to not only overcome cancer but also to embark on a career path aimed at helping others battling the disease highlights the indomitable spirit of cancer survivors,” concludes Dr Nagarkar.

About HCG Manavata Cancer Centre (HCGMCC): -

Established in 2007 by Dr Raj Nagarkar, HCGMCC – Nashik is Central India's first NABH-accredited facility. With over 50 consultant oncologists, 900 staff members and a 300-bed capacity, HCGMCC is a leading institution, offering holistic cancer treatment. Specializing in surgical, radiation and medical oncology, the centre has conducted 65,000 surgeries, including 1,000 robotic-assisted procedures. Patient-centric and multidisciplinary, HCGMCC recommends treatments to individual needs. Beyond clinical excellence, the centre’s financial aid programs underscore its commitment to accessibility and community well-being, redefining cancer care in the pursuit of a cancer-free future.

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Clinical Interventions in Chronic Hepatitis B and C: Antiviral Efficacy, Liver Fibrosis Scoring, and Monitoring August 11, 2026
Common Health Mistakes Indians Should Avoid: A Practical Guide to Everyday WellnessAugust 11, 2026
How to Build a Healthy Lifestyle After 40: A Practical Guide for Indian AdultsAugust 11, 2026
Milk Microbiome Could Hold New Clues to Lifelong Health, Experts SayAugust 10, 2026
Globally Renowned Dermatologist and Sesderma Founder Professor Dr. Gabriel Serrano to Visit India to Showcase Cutting-Edge Derma-Tech for Indian Skincare at Scientific Symposiums Hosted by Iberia PharmaceuticalsAugust 10, 2026
Sharda Hospital Celebrates World Breastfeeding Week with a Week-Long Awareness ProgrammeAugust 10, 2026
Swinburne University of Technology Opens Applications for Master of Engineering ScienceAugust 10, 2026
GLP-1 Receptor Agonists: A New Era in Weight Loss TreatmentAugust 10, 2026
Immunotherapy vs. Chemotherapy: Understanding the Mechanisms of Precision OncologyAugust 10, 2026
Mitigating Tech-Induced Ailments: Managing Screen Time, Sedentary Lifestyles, and Dry Eye SyndromeAugust 10, 2026
The Blueprint of Validation: Navigating Medical AI’s "Reckoning Year"August 10, 2026
The Future of Smart Hospitals: Redefining Healthcare Delivery in India August 10, 2026
Healthcare Data Security in India: Risks, Threats, and Best Practices for a Digital-First Health EcosystemAugust 10, 2026
The Science of Resilience: Psychological Strategies for Modern StressAugust 08, 2026
The Science of Fasting: 2026 Research on Autophagy and LongevityAugust 08, 2026
Early Markers of Insulin Resistance: Moving Beyond Fasting Blood SugarAugust 08, 2026
Healthcare Management Challenges in India: What Hospital Leaders Must Address NowAugust 08, 2026
Importance of Patient Safety: Why Every Hospital in India Must Prioritize ItAugust 08, 2026
Decoding Fatty Liver Disease: Symptoms, Reversibility, and the MASLD/NAFLD SpectrumAugust 07, 2026
Heart-Healthy Dietary Patterns: Translating Clinical Nutrition Guidelines into Daily MealsAugust 07, 2026